Multiple sclerosis: open trials in Romania

9 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Spitalul Clinic De Psihiatrie Si Neurologie Brasov, Brasov · Spitalul Clinic Cai Ferate Constanta, Constanța · Spitalul Clinic Judetean de Urgenta Targu Mures, Târgu Mureş
Registry updated 2026-11-03
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement
Clubul Sanatatii S.R.L., Campulung
Registry updated 2026-10-28
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Spitalul Clinic Cai Ferate Constanta, Constanța · Spitalul Municipal “Sf. Doctori Cosmasi Damian” Radauti, Radauti, jud. Suceava
Registry updated 2026-10-27
NCT05054140
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis
Trial Treatment · Phase 2 · Immunic AG
Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca
Registry updated 2026-10-23
2024-512914-16-00
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Trial Treatment · Phase 3 · Amgen Inc.
Arensia Clinics S.R.L., Bucharest · Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca
Registry updated 2026-10-20
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Bucharest · Novartis Investigative Site, Campulung Muscel · Novartis Investigative Site, Constanța
Registry updated 2026-10-13
2024-511686-11-00
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Spitalul Clinic de Psihiatrie Prof Dr Alexandru Obregia, Bucharest
Registry updated 2026-09-29
NCT06408259
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Dr. Victor Gomoiu Clinical Children Hospital, Bucharest · Spitalul Clinic de Psihiatrie Prof Dr Alexandru Obregia, Bucharest
Registry updated 2026-09-10
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Neurocity S.R.L., Bucharest · Clubul Sanatatii S.R.L., Campulung · Spitalul Clinic Cai Ferate Constanta, Constanța
Registry updated 2026-07-30

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error